CD46 and cancer: The vaccine lineage of the measles virus (MeV) is one of the most extensively investigated OVs that targets tumor cells by selectively binding to the membrane cofactor protein CD46 (MCP/CD46), frequently overexpressed in malignant tumors (https://www.proteinatlas.org/ENSG00000117335-CD46/pathology).